Literature DB >> 12464869

Assessment of routine elimination of postoperative nasogastric decompression after Roux-en-Y gastric bypass.

Sergio Huerta1, James R Arteaga, Mark P Sawicki, Carson D Liu, Edward H Livingston.   

Abstract

BACKGROUND: Anastomotic disruption after surgical intervention is an infrequent complication, but may lead to severe morbidity and mortality when it occurs. Of the various gastric procedures, the Roux-en-Y gastric bypass (RYGB) has one of the highest risks for anastomotic leakage. Consequently, a nasogastric tube (NGT) is frequently placed when these operations are performed. Most studies examining the outcomes for patients without postoperative NGTs have been relatively small with groups of patients undergoing a variety of operations. Assessing the incidence of anastomotic leaks by routine elimination of postoperative NGTs requires a large number of patients. In this study, we assessed the safety and efficacy of routine elimination of NGTs in a large cohort of patients undergoing a single operation.
METHODS: We reviewed our experience with 1067 patients who underwent RYGB at the UCLA medical center. Fifty-six patients had NGTs routinely placed before the implementation of a standard protocol, which eliminated postoperative NGT decompression. The complication rate for the RYGB patient cohort with and without postoperative NGT was compared.
RESULTS: We found no difference in the complication rates between the 2 groups (Fisher exact test; P =.21).
CONCLUSIONS: Our findings suggest that routine placement of an NGT after RYGB is unnecessary.

Entities:  

Mesh:

Year:  2002        PMID: 12464869     DOI: 10.1067/msy.2002.127678

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

Review 1.  Optimizing perioperative care in bariatric surgery patients.

Authors:  Daniel P Lemanu; Sanket Srinivasa; Primal P Singh; Sharon Johannsen; Andrew D MacCormick; Andrew G Hill
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

Review 2.  Canadian consensus statement: enhanced recovery after surgery in bariatric surgery.

Authors:  Jerry T Dang; Vivian G Szeto; Ahmad Elnahas; James Ellsmere; Allan Okrainec; Amy Neville; Samaad Malik; Ekua Yorke; Dennis Hong; Laurent Biertho; Timothy Jackson; Shahzeer Karmali
Journal:  Surg Endosc       Date:  2019-06-17       Impact factor: 4.584

3.  Early removing gastrointestinal decompression and early oral feeding improve patients' rehabilitation after colorectostomy.

Authors:  Tong Zhou; Xiao-Ting Wu; Ye-Jiang Zhou; Xiong Huang; Wei Fan; Yue-Chun Li
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 4.  Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations.

Authors:  A Thorell; A D MacCormick; S Awad; N Reynolds; D Roulin; N Demartines; M Vignaud; A Alvarez; P M Singh; D N Lobo
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

5.  Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  S Sauerland; L Angrisani; M Belachew; J M Chevallier; F Favretti; N Finer; A Fingerhut; M Garcia Caballero; J A Guisado Macias; R Mittermair; M Morino; S Msika; F Rubino; R Tacchino; R Weiner; E A M Neugebauer
Journal:  Surg Endosc       Date:  2004-12-02       Impact factor: 4.584

6.  Gastrointestinal decompression after excision and anastomosis of lower digestive tract.

Authors:  Wen-Zhang Lei; Gao-Ping Zhao; Zhong Cheng; Ka Li; Zong-Guang Zhou
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

Review 7.  Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update.

Authors:  Erik Stenberg; Luiz Fernando Dos Reis Falcão; Mary O'Kane; Ronald Liem; Dimitri J Pournaras; Paulina Salminen; Richard D Urman; Anupama Wadhwa; Ulf O Gustafsson; Anders Thorell
Journal:  World J Surg       Date:  2022-01-04       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.